SH3BP5 and diffuse large B-cell lymphoma: Notably, the SH3BP5 antigen expression was more frequently detected in ABC DLBCL patients than in germinal center B‐cell‐like (GCB) DLBCL patients (70% vs. 36%, P = 0.046).